Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Boswell

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Cell Reports. Medicine|March 2, 2022
SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivitySimone I Richardson, Nelia P Manamela, Boitumelo M Motsoeneng, et al.
Journal of Virology|July 22, 2022
Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus VariantsThandeka Moyo-Gwete, Mashudu Madzivhandila, Nonhlanhla N Mkhize, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 31, 2021
Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africaF Abdullah, J Myers, D Basu, et al.
Journal of Virology|July 2, 2024
SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunitySimone I Richardson, Nonkululeko Mzindle, Thopisang Motlou, et al.
Cell Host & Microbe|April 18, 2022
SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individualsSimone I Richardson, Vimbai Sharon Madzorera, Holly Spencer, et al.
Cell Reports. Medicine|April 27, 2022
Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concernDale Kitchin, Simone I Richardson, Mieke A van der Mescht, et al.
Cell Reports. Medicine|January 5, 2023
Antibody-dependent cellular cytotoxicity against SARS-CoV-2 Omicron sub-lineages is reduced in convalescent sera regardless of infecting variantSimone I Richardson, Prudence Kgagudi, Nelia P Manamela, et al.
Nature|February 1, 2022
T cell responses to SARS-CoV-2 spike cross-recognize OmicronRoanne Keeton, Marius B Tincho, Amkele Ngomti, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Cell Reports. Medicine|March 2, 2022
SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivitySimone I Richardson, Nelia P Manamela, Boitumelo M Motsoeneng, et al.
Journal of Virology|July 22, 2022
Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus VariantsThandeka Moyo-Gwete, Mashudu Madzivhandila, Nonhlanhla N Mkhize, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 31, 2021
Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africaF Abdullah, J Myers, D Basu, et al.
Journal of Virology|July 2, 2024
SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunitySimone I Richardson, Nonkululeko Mzindle, Thopisang Motlou, et al.
Cell Host & Microbe|April 18, 2022
SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individualsSimone I Richardson, Vimbai Sharon Madzorera, Holly Spencer, et al.
Cell Reports. Medicine|April 27, 2022
Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concernDale Kitchin, Simone I Richardson, Mieke A van der Mescht, et al.
Cell Reports. Medicine|January 5, 2023
Antibody-dependent cellular cytotoxicity against SARS-CoV-2 Omicron sub-lineages is reduced in convalescent sera regardless of infecting variantSimone I Richardson, Prudence Kgagudi, Nelia P Manamela, et al.
Nature|February 1, 2022
T cell responses to SARS-CoV-2 spike cross-recognize OmicronRoanne Keeton, Marius B Tincho, Amkele Ngomti, et al.
Pageof 7